ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes

被引：399
|
作者：
Jensen, Robert T. [1 ]
Cadiot, Guillaume [2 ]
Brandi, Maria L. [3 ]
de Herder, Wouter W. [4 ]
Kaltsas, Gregory [5 ]
Komminoth, Paul [6 ]
Scoazec, Jean-Yves [7 ]
Salazar, Ramon [8 ]
Sauvanet, Alain [7 ]
Kianmanesh, Reza [9 ]
机构：
[1] NIH, Digest Dis Branch, Cell Biol Sect, Bethesda, MD 20892 USA
[2] CHU Reims, Hop Robert Debre, Serv Hepatogastroenterol, Reims, France
[3] Univ Florence, Florence, Italy
[4] Erasmus MC Univ, Dept Endocrinol, Rotterdam, Netherlands
[5] Natl Univ Athens, Dept Pathophysiol, Athens, Greece
[6] Stadtspital Triemli, Inst Pathol, Zurich, Switzerland
[7] Hop Edouard Herriot, Hosp Civils Lyon, Serv Cent Anat & Cytol Pathol, Lyon, France
[8] Inst Catala Oncol IDIBELL, Dept Oncol, Barcelona, Spain
[9] Louis Mourier Univ Hosp, Dept Surg, Colombes, France
来源：
NEUROENDOCRINOLOGY | 2012年 / 95卷 / 02期
关键词：
ZOLLINGER-ELLISON-SYNDROME; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; PROTON PUMP INHIBITORS; INSTITUTES-OF-HEALTH; LIVER METASTASES; SURGICAL-MANAGEMENT; CUSHINGS-SYNDROME; MEDICAL-TREATMENT; GASTROENTEROPANCREATIC TUMORS; PROGNOSTIC-FACTORS;
D O I：
10.1159/000335591
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：98 / 119
页数：22
相关论文
共 39 条
  • [31] Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group
    Singh, Simron
    Dey, Chris
    Kennecke, Hagen
    Kocha, Walter
    Maroun, Jean
    Metrakos, Peter
    Mukhtar, Tariq
    Pasieka, Janice
    Rayson, Daniel
    Rowsell, Corwyn
    Sideris, Lucas
    Wong, Ralph
    Law, Calvin
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (08) : 2685 - 2699
  • [32] Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies
    Lee, Lingaku
    Ramos-Alvarez, Irene
    Jensen, Robert T.
    CANCERS, 2022, 14 (05)
  • [33] A novel classification of portal venous tumor invasion to predict residual tumor status after surgery in patients with pancreatic neuroendocrine neoplasms
    Kato, Tomotaka
    Kudo, Atsushi
    Kinowaki, Yuko
    Ishikawa, Yoshiya
    Watanabe, Shuichi
    Akahoshi, Keiichi
    Ogawa, Kosuke
    Ono, Hiroaki
    Ban, Daisuke
    Tanaka, Shinji
    Tanabe, Minoru
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (04) : 931 - 941
  • [34] Magnetic Resonance Imaging or Endoscopic Ultrasonography for Detection and Surveillance of Pancreatic Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1?
    Daskalakis, Kosmas
    Tsoli, Marina
    Alexandraki, Krystallenia I.
    Angelousi, Anna
    Chatzellis, Eleftherios
    Tsolakis, Apostolos V.
    Karoumpalis, Ioannis
    Kolomodi, Denise
    Kassi, Evanthia
    Kaltsas, Gregory
    HORMONE AND METABOLIC RESEARCH, 2019, 51 (09) : 580 - 585
  • [35] What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?
    Challis, Benjamin G.
    Casey, Ruth T.
    Grossman, Ashley
    Newell-Price, John
    Newey, Paul
    Thakker, Rajesh V.
    CLINICAL ENDOCRINOLOGY, 2019, 91 (06) : 708 - 715
  • [36] Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis
    Zheng, Mengzhen
    Li, Yan
    Li, Tong
    Zhang, Lianfeng
    Zhou, Lin
    CANCER MEDICINE, 2019, 8 (11): : 5128 - 5136
  • [37] Prognostic value of functional tumor burden on 68Ga-DOTATOC PET/CT in patients with pancreatic neuro-endocrine tumors
    Ohnona, J.
    Nataf, V
    Gauthe, M.
    Balogova, S.
    Benesty, O. Belissant
    Zhang-Yin, J.
    Talbot, J-N
    Montravers, F.
    NEOPLASMA, 2019, 66 (01) : 140 - 148
  • [38] Reliability and Agreement of Radiological and Pathological Tumor Size in Patients with Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors: Results from a Population-Based Cohort
    van Beek, Dirk-Jan
    Verkooijen, Helena M.
    Nell, Sjoerd
    Bonsing, Bert A.
    van Eijck, Casper H.
    van Goor, Harry
    Hoogwater, Frederik J. H.
    van Dijkum, Elisabeth J. M. Nieveen
    Kazemier, Geert
    Dejong, Cornelis H. C.
    Brosens, Lodewijk A. A.
    Wessels, Frank J.
    Rinkes, Inne H. M. Borel
    Valk, Gerlof D.
    Vriens, Menno R.
    NEUROENDOCRINOLOGY, 2021, 111 (08) : 705 - 717
  • [39] Evaluation of the details and importance of lymphatic, microvascular, and perineural invasion in patients with non-functioning pancreatic neuroendocrine neoplasms based on tumor size and the 2022 World Health Organization classification: a 23-year retrospective analysis
    Izumo, Wataru
    Kawaida, Hiromichi
    Saito, Ryo
    Nakata, Yuki
    Amemiya, Hidetake
    Maruyama, Suguru
    Takiguchi, Koichi
    Shoda, Katsutoshi
    Shiraishi, Kensuke
    Furuya, Shinji
    Kawaguchi, Yoshihiko
    Mochizuki, Kunio
    Kondo, Tetsuo
    Ichikawa, Daisuke
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2025, 23 (01)
1234